Outcome Referrals, Inc. Treatment Outcome Package (TOP)

$98/month per clinician (regular pricing $120/month per clinician) 1-800-329-0949 ext. 127

a better behavioral health assessment for primary care and pediatric patients

The Treatment Outcome Package (TOP), a Behavioral Health screening and outcomes toolkit, developed by David R. Kraus, PhD and a multi-disciplinary team of mental health providers, researchers, and technical experts offers complete, validated behavioral health assessment and outcomes measurement tools for primary care physicians and their patients.

TOP utilizes scientific research and analyses of the world’s largest dataset of over 1.5 million behavioral health patient outcomes. TOP results are validated, risk adjusted, and normed to the US “healthy” population. No other outcome measurement tool can compare to the sensitivity and accuracy of TOP’s patient assessments.

Easy to use for physicians and patients, the Treatment Outcome Package (TOP) is a standardized, HIPAA compliant, data-driven outcome measurement tool that can be delivered to patients and caregivers (raters) via smartphones, tablets or email prior to, or during appointments. The TOP screens for anxiety and depression as well as up to 13 domains of behavioral health.

Results are analyzed and returned to physicians in seconds for same day use. No paper forms, no staff time required to score results.

Accurately assess patients and monitor interventions, the TOP assessment, available in child (3-18 years), adolescent (11-21 years) and adult versions (16+ years), provides real-time feedback and informs clinicians if pediatric or primary care patients may need primary care interventions or behavioral health or psychiatric referrals. Repeat TOP assessments are valuable to assess responses to any behavioral health medications or interventions.

Billable and reimbursable, implementing the TOP is cost effective. We recommend talking with your billing department about how to maximize reimbursement rates for behavioral health assessments; or contact our office at 800-329-0949 ext. 127 to discuss how TOP can be a beneficial addition to your practice.

We offer EMR/EHR integration.– call us for more information

TOP Benefits

Below are the features we have built into the leading system.

TOP
Tools for children and adolescents
Tools for adults
Published validity studies on APA-defined dimensions (Concurrent & Predictive)
Multi-dimensions (depression, anxiety…) with published confirmation studies (Confirmatory Factor Analysis) that meet modern standards
Built-in reports for patients, providers and health plans
No royalty fees (i.e., no usage fees paid to tool owner)
Multiple raters with easy to read multi-rater reports
Emailed questions for easy patient completion
Fair provider benchmarking (risk-adjustment with >30% variance explained)
Best-matched provider referral service (protected by US Patent)
System predicts high cost and hospitalization risk (predictive analytics)
On-demand consultation and training
Live customer service

Recommendation

The U.S. Preventive Services Task Force (USPSTF) now recommends primary care and pediatric clinicians start screening for mental health symptoms in children and adolescents as follows:

Children and adolescents aged 8 to 18 years:The USPSTF recommends screening for anxiety in this age group regardless of symptoms.

Importance Anxiety disorder, a common mental health condition in the US, comprises a group of related conditions characterized by excessive fear or worry that present as emotional and physical symptoms. The 2018-2019 National Survey of Children’s Health (NSCH) found that 7.8% of children and adolescents aged 3 to 17 years had a current anxiety disorder. Anxiety disorders in childhood and adolescence are associated with an increased likelihood of a future anxiety disorder or depression.

Adolescents aged 12 to 18 years: The USPSTF recommends screening for major depressive disorder (MDD) in this age group regardless of symptoms.

Importance Depression is a leading cause of disability in the US. Children and adolescents with depression typically have functional impairments in their performance at school or work, as well as in their interactions with their families and peers. Depression can also negatively affect the developmental trajectories of affected youth. Major depressive disorder (MDD) in children and adolescents is strongly associated with recurrent depression in adulthood; other mental disorders; and increased risk for suicidal ideation, suicide attempts, and suicide completion.

Suicide is the second-leading cause of death among youth aged 10 to 19 years. Psychiatric disorders and previous suicide attempts increase suicide risk. Rates of suicide attempts and deaths vary by sex, age, and race and ethnicity.